Pot D A, Woodford T A, Remboutsika E, Haun R S, Dixon J E
Department of Biochemistry, Purdue University, West Lafayette, Indiana 47907.
J Biol Chem. 1991 Oct 15;266(29):19688-96.
This report describes the cloning and characterization of rat leukocyte common antigen-related protein (rLAR), a receptor-like protein tyrosine phosphatase (PTPase). The recombinant cytoplasmic PTPase domain was expressed at high levels in bacteria and purified to homogeneity. Kinetic properties of the PTPase were examined along with potential modulators of PTPase activity. Several sulfhydryl-directed reagents were effective inhibitors, and a surprising distinction between iodoacetate and iodoacetamide was observed. The latter compound was an extremely poor inhibitor when compared to iodoacetate, suggesting that iodoacetate may interact selectively with a positive charge at or near the active site of the enzyme. Site-directed mutants were made at 4 highly conserved cysteine residues found at positions 1434, 1522, 1723, and 1813 within the protein. The Cys-1522/Ser mutation resulted in a 99% loss of enzymatic activity of the pure protein. This observation is consistent with greater than 99% of the PTPase activity being found in the first domain of the PTPase and demonstrates the critical importance of this cysteine residue in catalysis. The recombinant C1522S mutant phosphatase could also be phosphorylated in vitro by protein kinase C and p43v-abl tyrosine kinase. When pure recombinant PTPase was mixed with 32P-labeled tyrosine substrate and then rapidly denatured, a 32P-labeled enzyme intermediate could be trapped and visualized by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The catalytically inactive C1522S mutant did not form the phosphoenzyme intermediate.
本报告描述了大鼠白细胞共同抗原相关蛋白(rLAR)的克隆与特性分析,rLAR是一种受体样蛋白酪氨酸磷酸酶(PTPase)。重组细胞质PTPase结构域在细菌中高水平表达并纯化至同质。研究了PTPase的动力学特性以及PTPase活性的潜在调节剂。几种巯基导向试剂是有效的抑制剂,并且观察到碘乙酸和碘乙酰胺之间存在惊人的差异。与碘乙酸相比,后一种化合物是一种极弱的抑制剂,这表明碘乙酸可能与酶活性位点或其附近的正电荷选择性相互作用。在该蛋白1434、1522、1723和1813位发现的4个高度保守的半胱氨酸残基处进行了定点突变。Cys-1522/Ser突变导致纯蛋白的酶活性丧失99%。这一观察结果与在PTPase的第一个结构域中发现超过99%的PTPase活性一致,并证明了该半胱氨酸残基在催化中的关键重要性。重组C1522S突变型磷酸酶在体外也可被蛋白激酶C和p43v-abl酪氨酸激酶磷酸化。当将纯重组PTPase与32P标记的酪氨酸底物混合,然后迅速变性时,可捕获32P标记的酶中间体,并通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳进行可视化。催化无活性的C1522S突变体未形成磷酸酶中间体。